Crescent Biopharma, Inc. (CBIO)
NASDAQ · Healthcare
Crescent Biopharma, Inc. Shareholder Equity 2012–2025
Crescent Biopharma, Inc. annual shareholder equity history from 2013 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Crescent Biopharma, Inc. shareholder equity as of December 31, 2025: 203.0M, a 428.48% increase year-over-year.
- Crescent Biopharma, Inc. shareholder equity for 2025 were 203.0M, a 428.48% increase from 2023.
- Crescent Biopharma, Inc. shareholder equity for 2023 were 38.4M, a 10.52% decrease from 2022.
- Crescent Biopharma, Inc. shareholder equity for 2022 were 42.9M, a 47.39% decrease from 2021.
- Crescent Biopharma, Inc. shareholder equity for 2021 were 81.6M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Crescent Biopharma, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $203 |
| 2023 | $38 |
| 2022 | $43 |
| 2021 | $82 |
| 2020 | $128 |
| 2016 | $35 |
| 2015 | $40 |
| 2014 | $51 |
| 2013 | $3 |
Crescent Biopharma, Inc. Shareholder Equity — FAQ
Crescent Biopharma, Inc. (CBIO) shareholder equity over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CBIO's shareholder equity history?
The chart and table above show Crescent Biopharma, Inc.'s shareholder equity by year and by quarter, including the growth rate.